Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Apply
LV20.19 & Pirtobrutinib
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step